Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017101
University of California Sys Office/Pres, Oakland, CA, United States
Search grants from University of California Sys Office/Pres
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Optimized Metabolite Extraction, Separation, and Identification for Metabolomics
Automated Image Plate Data Collection Equipment
Chronoendocrinology of Sleep Disturbances in Depression
Cooperative Cataract Research Group Consortium
Mathematical Sciences: Monomial Ideals, Local Cohomology, and the Number of Defining Equations
Recently added grants:
New Molecular Probes For Protein Kinases
Molecular characterization of the multi-modal regulation of inositol 1,4,5-trisphosphate receptors
Cell-type? and developmental stage?specific regulation of gene expression in the retina
Molecular Mechanisms Regulating and Interpreting BMP Signaling
International Federation of Placenta Associations
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017101-010
Application #
7191419
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
University of California Sys Office/Pres
Department
Type
DUNS #
003985512
City
Oakland
State
CA
Country
United States
Zip Code
94607
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
Comments
Be the first to comment on this grant